Cellosaurus WIL2 MTI-TG (CVCL_A6HS)
Cell line name | WIL2 MTI-TG |
---|---|
Synonyms | MTI-TG |
Accession | CVCL_A6HS |
Resource Identification Initiative | To cite this cell line use: WIL2 MTI-TG (RRID:CVCL_A6HS) |
Comments | Population: Caucasian. Selected for resistance to: ChEBI; CHEBI:44081; 6-methylthioinosine (6-methylmercaptopurine riboside). Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG). Transformant: ChEBI; CHEBI:23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE). Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV). Derived from site: In situ; Spleen; UBERON=UBERON_0002106. |
Sequence variations |
|
Disease | Hereditary spherocytosis (NCIt: C97074) Hereditary spherocytosis (ORDO: Orphanet_822) |
Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) |
Hierarchy | Parent: CVCL_A6HR (WIL2 MTIr-107) |
Sex of cell | Male |
Age at sampling | 5Y |
Category | Transformed cell line |
Publications | PubMed=197600; DOI=10.1126/science.197600 PubMed=893394; DOI=10.1016/S0021-9258(17)40020-2 |
Cross-references | |
Encyclopedic resources | Wikidata; Q107117458 |
Entry history | |
Entry creation | 20-May-2021 |
Last entry update | 29-Jun-2023 |
Version number | 4 |